Annual CFF
-$30.00 K
+$180.00 K+85.71%
31 December 2023
Summary:
Leap Therapeutics annual cash flow from financing activities is currently -$30.00 thousand, with the most recent change of +$180.00 thousand (+85.71%) on 31 December 2023. During the last 3 years, it has fallen by -$74.03 million (-100.04%). LPTX annual CFF is now -100.03% below its all-time high of $98.03 million, reached on 31 December 2021.LPTX Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$66.00 K
-$37.18 M-100.18%
30 September 2024
Summary:
Leap Therapeutics quarterly cash flow from financing activities is currently -$66.00 thousand, with the most recent change of -$37.18 million (-100.18%) on 30 September 2024. Over the past year, it has dropped by -$65.00 thousand (-6500.00%). LPTX quarterly CFF is now -100.07% below its all-time high of $97.26 million, reached on 30 September 2021.LPTX Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
$37.08 M
-$65.00 K-0.17%
30 September 2024
Summary:
Leap Therapeutics TTM cash flow from financing activities is currently $37.08 million, with the most recent change of -$65.00 thousand (-0.17%) on 30 September 2024. Over the past year, it has increased by +$37.11 million (+123700.00%). LPTX TTM CFF is now -62.18% below its all-time high of $98.03 million, reached on 31 December 2021.LPTX TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LPTX Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +85.7% | -6500.0% | +10000.0% |
| 3 y3 years | -100.0% | -100.1% | -61.9% |
| 5 y5 years | -100.2% | -105.3% | +150.6% |
LPTX Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | +85.7% | -100.1% | +68.6% | -62.2% | >+9999.0% |
| 5 y | 5 years | -100.0% | +85.7% | -100.1% | +82.9% | -62.2% | >+9999.0% |
| alltime | all time | -100.0% | +85.7% | -100.1% | +85.1% | -62.2% | >+9999.0% |
Leap Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$66.00 K(-100.2%) | $37.08 M(-0.2%) |
| June 2024 | - | $37.12 M(>+9900.0%) | $37.15 M(>+9900.0%) |
| Mar 2024 | - | $29.00 K(>+9900.0%) | $28.00 K(-193.3%) |
| Dec 2023 | -$30.00 K(-85.7%) | $0.00(-100.0%) | -$30.00 K(0.0%) |
| Sept 2023 | - | -$1000.00(<-9900.0%) | -$30.00 K(+3.4%) |
| June 2023 | - | $0.00(-100.0%) | -$29.00 K(0.0%) |
| Mar 2023 | - | -$29.00 K(<-9900.0%) | -$29.00 K(-86.2%) |
| Dec 2022 | -$210.00 K(-100.2%) | $0.00(0.0%) | -$210.00 K(-138.5%) |
| Sept 2022 | - | $0.00(0.0%) | $545.00 K(-99.4%) |
| June 2022 | - | $0.00(-100.0%) | $97.81 M(-0.0%) |
| Mar 2022 | - | -$210.00 K(-127.8%) | $97.81 M(-0.2%) |
| Dec 2021 | $98.03 M(+32.5%) | $755.00 K(-99.2%) | $98.03 M(+0.8%) |
| Sept 2021 | - | $97.26 M(>+9900.0%) | $97.28 M(<-9900.0%) |
| June 2021 | - | $4000.00(-71.4%) | -$367.00 K(-100.8%) |
| Mar 2021 | - | $14.00 K(>+9900.0%) | $48.41 M(-34.6%) |
| Dec 2020 | $74.00 M(+399.4%) | $0.00(-100.0%) | $74.00 M(+0.0%) |
| Sept 2020 | - | -$385.00 K(-100.8%) | $73.98 M(-2.2%) |
| June 2020 | - | $48.78 M(+90.5%) | $75.62 M(+169.1%) |
| Mar 2020 | - | $25.61 M(<-9900.0%) | $28.10 M(+89.6%) |
| Dec 2019 | $14.82 M(-6.8%) | -$19.00 K(-101.5%) | $14.82 M(+0.1%) |
| Sept 2019 | - | $1.25 M(-0.5%) | $14.80 M(+9.8%) |
| June 2019 | - | $1.26 M(-89.8%) | $13.47 M(+1.9%) |
| Mar 2019 | - | $12.32 M(<-9900.0%) | $13.22 M(-16.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $15.91 M(-66.7%) | -$40.00 K(-40.3%) | $15.91 M(-53.0%) |
| Sept 2018 | - | -$67.00 K(-106.6%) | $33.84 M(-0.2%) |
| June 2018 | - | $1.01 M(-93.3%) | $33.91 M(+3.0%) |
| Mar 2018 | - | $15.01 M(-16.1%) | $32.92 M(-31.1%) |
| Dec 2017 | $47.76 M(+86.4%) | $17.89 M(>+9900.0%) | $47.76 M(+30.5%) |
| Sept 2017 | - | $0.00(-100.0%) | $36.59 M(-14.1%) |
| June 2017 | - | $20.00 K(-99.9%) | $42.59 M(-12.3%) |
| Mar 2017 | - | $29.85 M(+344.3%) | $48.57 M(+89.6%) |
| Dec 2016 | $25.62 M(+209.8%) | $6.72 M(+12.0%) | $25.62 M(-5.7%) |
| Sept 2016 | - | $6.00 M(0.0%) | $27.15 M(+28.3%) |
| June 2016 | - | $6.00 M(-13.0%) | $21.17 M(+39.6%) |
| Mar 2016 | - | $6.90 M(-16.4%) | $15.17 M(+83.4%) |
| Dec 2015 | $8.27 M(-82.4%) | $8.25 M(>+9900.0%) | $8.27 M(>+9900.0%) |
| Sept 2015 | - | $16.00 K(>+9900.0%) | $14.00 K(-100.0%) |
| Mar 2015 | - | $0.00(-100.0%) | $46.89 M(0.0%) |
| Dec 2014 | $46.89 M(+241.0%) | -$2000.00(-100.0%) | $46.89 M(-0.0%) |
| Sept 2014 | - | $47.33 M(<-9900.0%) | $46.89 M(+252.4%) |
| June 2014 | - | -$443.00 K(<-9900.0%) | $13.31 M(-3.2%) |
| Mar 2014 | - | $0.00(0.0%) | $13.75 M(0.0%) |
| Dec 2013 | $13.75 M(+11.8%) | $0.00(-100.0%) | $13.75 M(0.0%) |
| Sept 2013 | - | $13.75 M(>+9900.0%) | $13.75 M(>+9900.0%) |
| June 2013 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2013 | - | $0.00 | $0.00 |
| Dec 2012 | $12.29 M | - | - |
FAQ
- What is Leap Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Leap Therapeutics?
- What is Leap Therapeutics annual CFF year-on-year change?
- What is Leap Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Leap Therapeutics?
- What is Leap Therapeutics quarterly CFF year-on-year change?
- What is Leap Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Leap Therapeutics?
- What is Leap Therapeutics TTM CFF year-on-year change?
What is Leap Therapeutics annual cash flow from financing activities?
The current annual CFF of LPTX is -$30.00 K
What is the all time high annual CFF for Leap Therapeutics?
Leap Therapeutics all-time high annual cash flow from financing activities is $98.03 M
What is Leap Therapeutics annual CFF year-on-year change?
Over the past year, LPTX annual cash flow from financing activities has changed by +$180.00 K (+85.71%)
What is Leap Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of LPTX is -$66.00 K
What is the all time high quarterly CFF for Leap Therapeutics?
Leap Therapeutics all-time high quarterly cash flow from financing activities is $97.26 M
What is Leap Therapeutics quarterly CFF year-on-year change?
Over the past year, LPTX quarterly cash flow from financing activities has changed by -$65.00 K (-6500.00%)
What is Leap Therapeutics TTM cash flow from financing activities?
The current TTM CFF of LPTX is $37.08 M
What is the all time high TTM CFF for Leap Therapeutics?
Leap Therapeutics all-time high TTM cash flow from financing activities is $98.03 M
What is Leap Therapeutics TTM CFF year-on-year change?
Over the past year, LPTX TTM cash flow from financing activities has changed by +$37.11 M (+123700.00%)